TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo December 26, 2023 Clarke Neumann, Esq. General Counsel Biora Therapeutics, Inc. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 Re: Biora Therapeutics, Inc. Registration Statement on Form S-3 Filed December 22, 2023 File No. 333-276260 Dear Clarke Neumann: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Stewart L. McDowell, Esq.